RPSA and lung carcinoma: In conclusion, this study reveals siRNA‐mediated downregulation of LRP/LR inhibits several key cancer hallmarks in lung cancer cells including Resistance to cell death, Activation of metastasis, Enabling replicative immortality, and Evasion of immune destruction.